Development Level

Tchem 2 | 1,890
Tbio 1 | 10,625
Tclin 1 | 602

IMPC Term

increased circulating alanine ... 2 | 11
increased circulating aspartat... 2 | 17
abnormal behavior 1 | 226
abnormal lung morphology 1 | 15
abnormal retina morphology 1 | 100
decreased circulating serum al... 1 | 79
increased circulating HDL chol... 1 | 63
increased circulating alkaline... 1 | 119
increased circulating choleste... 1 | 53
increased circulating potassiu... 1 | 31
increased circulating triglyce... 1 | 24
increased lactate dehydrogenas... 1 | 3
increased lean body mass 1 | 107
preweaning lethality, incomple... 1 | 260

Disease

Liver disease 3 | 219
Adverse reaction to drug 2 | 54
Bilirubin metabolic disorder 2 | 39
Cancer 2 | 2,346
Cardiovascular system disease 2 | 194
Cholelithiasis 2 | 14
Cholestasis 2 | 93
Cholestasis of pregnancy 2 | 5
Colorectal Neoplasms 2 | 217
Intrahepatic cholestasis 2 | 19
Leber congenital amaurosis 2 | 72
Liver diseases 2 | 66
Metabolic syndrome X 2 | 155
Peripheral Neuropathy 2 | 303
Acute kidney injury 1 | 65
Afibrinogenemia 1 | 4
Atrophic 1 | 10
Autoimmune hepatitis 1 | 13
Autoimmune polyendocrine syndrome 1 | 6
Calculus in biliary tract 1 | 2
Carcinoma, Small Cell 1 | 8
Cholangitis 1 | 20
Cholelithiasis Prevention 1 | 1
Cholestasis, Progressive Familial Intrahepatic, 2 1 | 1
Cholestasis, benign recurrent intrahepatic 2 1 | 1
Chronic Obstructive Airway Disease 1 | 47
Contact Dermatitis 1 | 80
Crigler Najjar syndrome, type 1 1 | 2
Crigler Najjar syndrome, type 2 1 | 2
Crigler-Najjar syndrome 1 | 1
Crohn Disease 1 | 97
Diabetes Mellitus, Non-Insulin-Dependent 1 | 157
Diabetes mellitus type 2 1 | 69
Diarrhea 1 | 155
Dihydropyrimidine Dehydrogenase Deficiency 1 | 6
Drug-Induced Liver Injury 1 | 118
Extravasation of Diagnostic and Therapeutic Materials 1 | 6
Fatty liver disease 1 | 84
Fragile X syndrome 1 | 31
Gilbert Disease (disorder) 1 | 1
Gilbert syndrome 1 | 3
Glucosephosphate dehydrogenase deficiency 1 | 15
Growth Disorders 1 | 33
Hepatomegaly 1 | 10
Hodgkin Disease 1 | 16
Hyperbilirubinemia 1 | 4
Intestinal Neoplasms 1 | 11
Keratoconjunctivitis sicca 1 | 19
Kernicterus 1 | 12
Liver Cirrhosis, Experimental 1 | 108
Liver Neoplasms, Experimental 1 | 48
Liver carcinoma 1 | 217
Liver neoplasms 1 | 109
Lucey-Driscoll syndrome (disorder) 1 | 1
Lung Injury 1 | 20
Lung Neoplasms 1 | 171
Methemoglobinemia 1 | 17
Neonatal jaundice 1 | 15
Neural Tube Defects 1 | 27
Neutropenia 1 | 78
Obesity 1 | 616
Ornithine carbamoyltransferase deficiency 1 | 13
Porphyria cutanea tarda 1 | 12
Precursor Cell Lymphoblastic Leukemia Lymphoma 1 | 42
Prevention of Cardiac Transplant Rejection 1 | 14
Prevention of Kidney Transplant Rejection 1 | 16
Prevention of Liver Transplant Rejection 1 | 14
Primary biliary cirrhosis 1 | 43
Primary cholangitis 1 | 2
Progressive intrahepatic cholestasis (disorder) 1 | 3
Pruritus 1 | 6
Rheumatoid Arthritis 1 | 1,160
Schizophrenia 1 | 501
Sclerosing cholangitis 1 | 16
Severe Recalcitrant Psoriasis 1 | 11
Sickle cell anemia 1 | 35
Splenic Diseases 1 | 3
Splenomegaly 1 | 7
Squamous cell carcinoma 1 | 94
Tear film insufficiency 1 | 14
Thalassemia 1 | 46
Type 2 diabetes mellitus 1 | 189
active Crohn's disease 1 | 918
aldosterone-producing adenoma 1 | 664
hepatocellular carcinoma 1 | 532
interstitial cystitis 1 | 2,299
intraductal papillary-mucinous adenoma (IPMA) 1 | 2,956
intraductal papillary-mucinous carcinoma (IPMC) 1 | 2,988
malignant mesothelioma 1 | 3,162
medulloblastoma, large-cell 1 | 6,234
nephrosclerosis 1 | 329
osteosarcoma 1 | 7,933
ovarian cancer 1 | 8,484
pancreatic ductal adenocarcinoma liver metastasis 1 | 1,795
posterior fossa group A ependymoma 1 | 1,511
psoriasis 1 | 6,685
substance-related disorder 1 | 105
ulcerative colitis 1 | 2,087
urothelial carcinoma 1 | 318

Tissue

Digestive Tract 4 | 18,473
Female tissues 4 | 18,647
Liver and Pancreas 4 | 18,136
Male tissues 4 | 17,969
Skin and soft tissues 4 | 18,115
Urinary Tract 4 | 18,444
Blood and immune system 3 | 17,995
Cardiovascular System 3 | 17,958
Endocrine System 3 | 18,512
Nervous System 3 | 18,561
Respiratory system 3 | 17,484

Target Family

Enzyme 1 | 4,146
Non-IDG 1 | 11,971
Nuclear Receptor 1 | 48
Transporter 1 | 473

Grant Application

1R15AT007705-01A1 4 | 4
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Bile acid receptor NR1H4 Tclin Nuclear Receptor -2.48530 306.4 272
UDP-glucuronosyltransferase 1-1 UGT1A1 Tbio Enzyme -2.91728 893.9 126
Bile salt export pump ABCB11 Tchem Transporter -2.77114 639.9 130
Cytochrome P450 1A2 CYP1A2 Tchem Non-IDG -3.30248 2022.5 420